Home The Word Brain My Amedeo FAQ Privacy About   


Chinese Coaching

Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.


  Cervical Cancer, January 2025

Free Subscription


Abstracts

Retrieve all available abstracts of the following 294 articles:
HTML format


 

Single Articles

  1. ZHAO X, Yang L, Pan J, Zeng Z, et al
    CXCL8 modulates M0 macrophage proliferation and polarization to influence tumor progression in cervical cancer.
    Sci Rep. 2025;15:790.
    PubMed    
    Abstract available

  2. LIU Z, Liu J, Wu Y, Zhou Z, et al
    Shared chemoresistance genes in ESCC and cervical Cancer: Insights from pharmacogenomics and Mendelian randomization.
    Int Immunopharmacol. 2025;147:113933.
    PubMed    
    Abstract available

  3. QIN L, Ding X
    Effect of zoledronic acid on biological characteristics of cervical cancer cells.
    Afr J Reprod Health. 2024;28:46-55.
    PubMed    
    Abstract available

  4. FRANCOEUR AA, Monk BJ, Tewari KS
    Treatment advances across the cervical cancer spectrum.
    Nat Rev Clin Oncol. 2025 Jan 3. doi: 10.1038/s41571-024-00977.
    PubMed    
    Abstract available

  5. ZHANG Z, Yu X, Cheng G
    Vitamin D sensitizes cervical cancer to radiation-induced apoptosis by inhibiting autophagy through degradation of Ambra1.
    Cell Death Discov. 2025;11:1.
    PubMed    
    Abstract available

  6. LIAO D, Cui Y, Shi L, Zeng S, et al
    USP34 regulates PIN1-cGAS-STING axis-dependent ferroptosis in cervical cancer via SUMOylation.
    Int Immunopharmacol. 2025;147:113968.
    PubMed    
    Abstract available

  7. HONG MK, Chiang CH, Cheng CH, Chu TY, et al
    Anti-Estrogen Therapy Achieves Complete Remission and Stability in Recurrent Cervical Cancer: A Case Study.
    Am J Case Rep. 2025;26:e946296.
    PubMed    
    Abstract available

  8. TEWARI KS
    Cervical Cancer.
    N Engl J Med. 2025;392:56-71.
    PubMed    


  9. WANG Y, Liu X, Liu J, Liu L, et al
    Should all cervical cancer patients with positive lymph node receive definitive radiotherapy: a population-based comparative study.
    Arch Gynecol Obstet. 2025 Jan 3. doi: 10.1007/s00404-024-07896.
    PubMed    
    Abstract available

  10. WANG Y, Zhou B, Lian X, Yu S, et al
    KIF18A Is a Novel Target of JNK1/c-Jun Signaling Pathway Involved in Cervical Tumorigenesis.
    J Cell Physiol. 2025;240:e31516.
    PubMed    
    Abstract available

  11. CHEN Q, Zang L, Xu Q, Wang M, et al
    The Association Between D-Dimer Levels and Recurrence in Patients with Early-Stage Cervical Cancer after Surgical Treatment.
    Int J Womens Health. 2024;16:2333-2342.
    PubMed    
    Abstract available

  12. YANG C, Hassan HA, Omar NF, Soo TH, et al
    Effects of amide proton transfer imaging in diagnosis, grading and prognosis prediction of cervical cancer: A systematic review and meta-analysis.
    Heliyon. 2024;10:e40291.
    PubMed    
    Abstract available

  13. SPINDLER KG, Jakobsen AV, Eriksen JG, Fokdal L, et al
    The clinical utility of circulating human papillomavirus across squamous cell carcinomas.
    Acta Oncol. 2025;64:1-12.
    PubMed    
    Abstract available

  14. KRISHNA A, Makkapatti BS, Athiyamaan MS, Lobo D, et al
    Decoding the influence of external beam radiotherapy to brachytherapy duration and overall treatment on response and early recurrences in cervical cancer patients treated with chemoradiation.
    Radiat Oncol J. 2024;42:257-262.
    PubMed    
    Abstract available

  15. ZHANG J, Zhang Y, Li X, Bao Y, et al
    Has_circ_ASH1L acts as a sponge for miR-1254 to promote the malignant progression of cervical cancer by targeting CD36.
    Cancer Gene Ther. 2025 Jan 2. doi: 10.1038/s41417-024-00866.
    PubMed    
    Abstract available

  16. PANG W, Qiu Y, Jin S, Jiang H, et al
    Label credibility correction based on cell morphological differences for cervical cells classification.
    Sci Rep. 2025;15:2.
    PubMed    
    Abstract available

  17. JIA Y, Yang N, Tang S, Deng L, et al
    RUNX1 promotes proliferation of cervical cancer through TGFB2-MAPK pathway.
    Sci Rep. 2025;15:497.
    PubMed    
    Abstract available

  18. SUVANASUTHI R, Therasakvichya S, Kanchanapiboon P, Promptmas C, et al
    Analysis of precancerous lesion-related microRNAs for early diagnosis of cervical cancer in the Thai population.
    Sci Rep. 2025;15:142.
    PubMed    
    Abstract available

  19. ESWARAN S, Bhat S, Upadhya D, Mascarenhas R, et al
    Biological functions of extracellular vesicle double C2-like domain beta in cervical cancer.
    Sci Rep. 2025;15:477.
    PubMed    
    Abstract available

  20. AKGOR U, Temiz BE, Gultekin M
    Prevention of gynecological cancers: cervical cancer screening in Turkey: a role model for the world.
    Curr Opin Obstet Gynecol. 2025;37:30-36.
    PubMed    
    Abstract available

  21. AKGOR U, Temiz BE, Gultekin M
    Prevention of gynecological cancers: cervical cancer screening in Turkey: a role model for the world.
    Curr Opin Obstet Gynecol. 2024 Dec 9. doi: 10.1097/GCO.0000000000000998.
    PubMed    
    Abstract available

  22. TALIHATI Z, Abudurousuli K, Hailati S, Han M, et al
    Screening of Hub Genes and Therapeutic Drugs in Cervical Cancer Using Integrated Bioinformatics Analysis.
    J Cancer. 2025;16:92-109.
    PubMed    
    Abstract available

  23. KOU Y, Tang X, Liang D, Xie C, et al
    HPV genotypes in invasive cervical cancer: prevalence, risk attribution, and optimized vaccine strategies in western China.
    Front Public Health. 2024;12:1455931.
    PubMed    
    Abstract available

  24. AGARWAL R, King JB, Gopalani SV, Senkomago V, et al
    Cervical cancer incidence and trends among women aged 15-29 years by county-level economic status and rurality - United States, 2007-2020.
    Cancer Epidemiol. 2024;94:102730.
    PubMed    
    Abstract available

  25. XIE S, Liu M, Li W
    Impact of Radiotherapy on Endocrine Function and Gut Microbiota in Cervical Cancer Patients Undergoing Ovarian Transposition.
    Int J Womens Health. 2024;16:2319-2331.
    PubMed    
    Abstract available

  26. ZHOU L, Liu J, Yao P, Liu X, et al
    Spatial transcriptomics reveals unique metabolic profile and key oncogenic regulators of cervical squamous cell carcinoma.
    J Transl Med. 2024;22:1163.
    PubMed    
    Abstract available

  27. BAIK D, Kim BW, Ha Y, Oh JK, et al
    Awareness, knowledge, and attitude toward cervical cancer screening and prevention in Uganda.
    Public Health. 2024;238:310-316.
    PubMed    
    Abstract available

  28. LIU Q, Yang J, Cheng H, Shu C, et al
    A Clinical Prediction Model for Pathologic Upgrade to Invasive Carcinoma Following Conization of Cervical High-Grade Squamous Intraepithelial Lesions.
    Cancer Med. 2025;14:e70540.
    PubMed    
    Abstract available

  29. BUADI LO, Odame R, Samba A, Kareem M, et al
    Integration and acceptability of cervical cancer screening as part of postnatal care among women attending postnatal clinics in the Accra Metropolis, Greater Accra Region, Ghana.
    PLOS Glob Public Health. 2024;4:e0004070.
    PubMed    
    Abstract available

  30. CHAN DNS, Choi KC, So WKW
    Effects of Web-Based Decision Aid to Support Cervical Cancer Screening Decision Among Young Working Women: A Pilot Randomised Controlled Trial.
    Int J Behav Med. 2024 Dec 30. doi: 10.1007/s12529-024-10344.
    PubMed    
    Abstract available

  31. ZHANG C, Tian W, Zhou X, Li L, et al
    Outcomes of Laparoscopic Radical Hysterectomy in Ia1-Ib1 Cervical Cancer Patients: A Multi-Center Study with 10 Years' Experiences in the Real World.
    Ann Surg Oncol. 2024 Dec 29. doi: 10.1245/s10434-024-16637.
    PubMed    
    Abstract available

  32. YANG H, Aydi W, Innab N, Ghoneim ME, et al
    Classification of cervical cancer using Dense CapsNet with Seg-UNet and denoising autoencoders.
    Sci Rep. 2024;14:31764.
    PubMed    
    Abstract available

  33. GEEITHA S, Prabha KPR, Cho J, Easwaramoorthy SV, et al
    Bidirectional recurrent neural network approach for predicting cervical cancer recurrence and survival.
    Sci Rep. 2024;14:31641.
    PubMed    
    Abstract available

  34. MITRA S, Sahu SK, Lakshminarayanan S, Raja K, et al
    Cascade of care for people with positive symptoms of common cancers in selected primary health centres of Puducherry: An explanatory mixed-method study.
    Indian J Med Res. 2024;160:457-465.
    PubMed    
    Abstract available

  35. ZHOU M, Li H, Geng X, Dai H, et al
    Risk Factors of Catheter-Associated Urinary Tract Infections Following Radical Hysterectomy for Cervical Cancer: A Propensity Score Matching-Based Study.
    Int J Womens Health. 2024;16:2297-2309.
    PubMed    
    Abstract available

  36. FU W, Xu Q, Lu H, Yang Y, et al
    Effectiveness of continuity of care in postoperative patients with cervical cancer: a systematic evaluation and meta-analysis of a randomized controlled trial.
    Front Oncol. 2024;14:1461296.
    PubMed    
    Abstract available

  37. CUSTODIO DIAS DUARTE B, Ribeiro Queiroz F, Percinio Costa A, Borges de Melo Neto A, et al
    Upregulation of long non-coding RNA ENSG00000267838 is related to the high risk of progression and non-response to chemoradiotherapy treatment for cervical cancer.
    Noncoding RNA Res. 2024;11:104-114.
    PubMed    
    Abstract available

  38. ZHAO Z, Yu P, Wang Y, Li H, et al
    Silencing of STEAP3 suppresses cervical cancer cell proliferation and migration via JAK/STAT3 signaling pathway.
    Cancer Metab. 2024;12:40.
    PubMed    
    Abstract available

  39. MNGQIBISA R, Chen H, Godfrey C, Sebitloane M, et al
    Extensive cervical lesion and treatment outcomes in women with HIV/HPV co-infection.
    AIDS Res Ther. 2024;21:101.
    PubMed    
    Abstract available

  40. CHEN Y, Li X, Yuan L, Yuan Y, et al
    Development and validation of a nomogram for predicting venous thromboembolism risk in post-surgery patients with cervical cancer.
    World J Surg Oncol. 2024;22:354.
    PubMed    
    Abstract available

  41. KURTAY S, Tasin C
    Healthcare access and cervical cancer awareness among Syrian refugee women in Turkiye: language, cultural, and economic challenges.
    BMC Public Health. 2024;24:3610.
    PubMed    
    Abstract available

  42. GU Y, Li T, Zhang M, Chen J, et al
    The Display between HPV Infection and Host Immunity in Cervical Cancer.
    Front Biosci (Landmark Ed). 2024;29:426.
    PubMed    
    Abstract available

  43. LI J, Ma Y, Wu Q, Ping P, et al
    The potential role of HPV oncoproteins in the PD-L1/PD-1 pathway in cervical cancer: new perspectives on cervical cancer immunotherapy.
    Front Oncol. 2024;14:1488730.
    PubMed    
    Abstract available

  44. YUSUF FZ, Kebede T, Abera MT, Bedane A, et al
    Comparative Analysis of Clinical and Radiologic Staging of Cervical Cancer: A Cross-Sectional Study in Ethiopia.
    Ethiop J Health Sci. 2024;34.
    PubMed    
    Abstract available

  45. TIAN X, Weng D, Chen Y, Wang Y, et al
    Risk assessment and triage strategy of cervical cancer primary screening on HPV integration status: 5-year follow-up of a prospective cohort study.
    J Natl Cancer Cent. 2024;4:311-317.
    PubMed    
    Abstract available

  46. DAUNGSUPAWONG H, Wiwanitkit V
    3D-printed template assisted intracavitary/interstitial brachytherapy for cervical cancer using repeat FMEA: Correspondence.
    Brachytherapy. 2024 Dec 28:S1538-4721(24)00401.
    PubMed    


  47. DIRAKWARANON W, Suwannarurk K, Chitkoolsamphan Y, Wisarnsirirak P, et al
    Sexual Dysfunction in Patient's Diagnosed with Cervical Cancer in Comparison to the Healthy Female Population.
    Asian Pac J Cancer Prev. 2024;25:4391-4396.
    PubMed    
    Abstract available

  48. SHAMSUTDINOVA A, Kulkayeva G, Karashutova Z, Tanabayev B, et al
    Analysis of the Effectiveness and Coverage of Breast, Cervical, and Colorectal Cancer Screening Programs in Kazakhstan for the Period 2021-2023: Regional Disparities and Coverage Dynamics.
    Asian Pac J Cancer Prev. 2024;25:4371-4380.
    PubMed    
    Abstract available

  49. ARECHKIK A, El Hatimi M, Amehmoud H, Mahlaq S, et al
    Health Related Quality of Life and Religiosity of Women with Cervical Cancer in the Souss-Massa Region, Morocco: A Cross-Sectional Study.
    Asian Pac J Cancer Prev. 2024;25:4351-4358.
    PubMed    
    Abstract available

  50. JOSHI S, Kumar BK, Ramshankar V, Maitra N, et al
    Performance of HPV Self-Sample Collected by a Novel Kit in Comparison with Clinician Collected Sample for Cervical Cancer Screening.
    Asian Pac J Cancer Prev. 2024;25:4211-4216.
    PubMed    
    Abstract available

  51. WATTANATHAVORN W, Buranapraditkun S, Kitkumthorn N, Bhattarakosol P, et al
    Effect of NQO1 Downregulation on the Migration and Invasion of HPV16-Positive Cervical Cancer Cells.
    Asian Pac J Cancer Prev. 2024;25:4189-4200.
    PubMed    
    Abstract available

  52. WANG H, Yang Y, Zhang E, Wang D, et al
    LncRNA PGM5-AS1 Impairs the Resistance of Cervical Cancer to Cisplatin by Regulating the Hippo and PI3K-AKT Pathways.
    Biochem Genet. 2024 Dec 28. doi: 10.1007/s10528-024-11011.
    PubMed    
    Abstract available

  53. CHEN Q, Zhai B, Li J, Wang H, et al
    Systemic immune-inflammatory index predict short-term outcome in recurrent/metastatic and locally advanced cervical cancer patients treated with PD-1 inhibitor.
    Sci Rep. 2024;14:31528.
    PubMed    
    Abstract available

  54. WELCH EC, Lu C, Sung CJ, Zhang C, et al
    BMT: A Cross-Validated ThinPrep Pap Cervical Cytology Dataset for Machine Learning Model Training and Validation.
    Sci Data. 2024;11:1444.
    PubMed    
    Abstract available

  55. SHARAFABAD BE, Abdoli A, Jamour P, Dilmaghani A, et al
    The ability of clostridium novyi-NT spores to induce apoptosis via the mitochondrial pathway in mice with HPV-positive cervical cancer tumors derived from the TC-1 cell line.
    BMC Complement Med Ther. 2024;24:427.
    PubMed    
    Abstract available

  56. LIU S, Wei Z, Ding H
    Correction: The role of the SOX2 gene in cervical cancer: focus on ferroptosis and construction of a predictive model.
    J Cancer Res Clin Oncol. 2024;151:27.
    PubMed    


  57. SIMANULLANG RH, Siahaan JM, Situmorang PC
    Histological Alterations of Cervical Cancer Following Zanthoxylum acanthopodium DC Therapy in Relation to E7, pRb, EGFR and p16 Expression.
    Pak J Biol Sci. 2024;27:602-612.
    PubMed    
    Abstract available

  58. ZHANG L, Yang L, Wang Y, Sun M, et al
    Clinical comparative study of robot-assisted and traditional laparoscopic surgery in patients with cervical cancer: a retrospective cohort study.
    BMC Surg. 2024;24:423.
    PubMed    
    Abstract available

  59. MATSUMURA N, Mandai M
    PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs; approval of pembrolizumab for locally advanced uterine cervical cancer, and durvalumab and olaparib for advanced or recurrent endometrial cancer in Japan.
    Int J Clin Oncol. 2024 Dec 28. doi: 10.1007/s10147-024-02679.
    PubMed    


  60. JOSEPH A, Balogun O, Adegboyega B, Salako O, et al
    Development and implementation of a 3d-HDR brachytherapy program for cervical cancer in a sub-Saharan African centre.
    Brachytherapy. 2024 Dec 26:S1538-4721(24)00402.
    PubMed    
    Abstract available

  61. RORIG L, Ruckriegl S, Gallwas J, Grundker C, et al
    G Protein-coupled Estrogen Receptor 1 (GPER1) Regulates Expression of SERPINE1/PAI-1 and Inhibits Tumorigenic Potential of Cervical Squamous Cell Carcinoma Cells In Vitro.
    Cancer Genomics Proteomics. 2025;22:13-23.
    PubMed    
    Abstract available

  62. KOH JW, Park SJ
    RFC3 Knockdown Decreases Cervical Cancer Cell Proliferation, Migration and Invasion.
    Cancer Genomics Proteomics. 2025;22:127-135.
    PubMed    
    Abstract available

  63. HUANG DH, Li YZ, Xu HL, Liu FH, et al
    Proteomics for Biomarker Discovery in Gynecological Cancers: A Systematic Review.
    J Proteome Res. 2025;24:1-12.
    PubMed    
    Abstract available

  64. ARIOKA M, Yi W, Igawa K, Ishikane S, et al
    Differentiation-inducing factor-1 inhibits EMT by proteasomal degradation of TAZ and YAP in cervical and colon cancer cell lines.
    Eur J Pharmacol. 2025;987:177184.
    PubMed    
    Abstract available

  65. WANG S, Dang L, Yin J, Duan X, et al
    Risk assessment of careHPV testing for the detection of cervical precancerous lesions: 5-year follow-up of a screening program in China.
    J Infect Public Health. 2025;18:102611.
    PubMed    
    Abstract available

  66. MA J, Lu W, Sun S, Zhan Y, et al
    The influencing factors in intention making-decision of Human papillomavirus vaccine in Chinese college students: A qualitative study.
    Patient Educ Couns. 2025;131:108594.
    PubMed    
    Abstract available

  67. VITI J, Di Stefano C, Giunti S, Pompeo G, et al
    Thin-layer cervical sample evaluation: Conventional light microscopy versus digital whole-slide imaging.
    Cancer Cytopathol. 2025;133:e22921.
    PubMed    
    Abstract available

  68. ZHOU Y, Liu J, Chen S, Xin X, et al
    Correlation of different HPV genotype viral loads and cervical lesions: A retrospective analysis of 1585 cases.
    Cancer Cytopathol. 2025;133:e22920.
    PubMed    
    Abstract available

  69. HARINATH L, Elishaev E, Ye Y, Matsko J, et al
    Analysis of the sensitivity of high-grade squamous intraepithelial lesion Pap diagnosis and interobserver variability with the Hologic Genius Digital Diagnostics System.
    Cancer Cytopathol. 2025;133:e22918.
    PubMed    
    Abstract available

  70. TAKIGAWA W, Yoshida H, Kitamura S, Tokutake C, et al
    Intraoperative peritoneal cytology for cervical gastric-type adenocarcinoma: Cytopathology and clinical impact.
    Cancer Cytopathol. 2025;133:e22915.
    PubMed    
    Abstract available

  71. WANG F, Zhen H, Yu K, Liu P, et al
    The Prognostic Value of Sarcopenia in Clinical Outcomes in Cervical Cancer: A Systematic Review and Meta-Analysis.
    J Cachexia Sarcopenia Muscle. 2025;16:e13674.
    PubMed    
    Abstract available

  72. IBANEZ R, Roura E, Morey F, Andujar M, et al
    Agreement Between High-Risk Human Papillomavirus Testing in Paired Self-Collected and Clinician-Collected Samples from Cervical Cancer Screening in Spain.
    Cancers (Basel). 2024;17:63.
    PubMed    
    Abstract available

  73. SCHOONHOVEN FJM, Aarts JWM, Fons G, Stalpers LJA, et al
    Impact of the Number of Positive Pelvic Lymph Nodes on Risk of Para-Aortic Recurrence in Patients with Clinically Early Cervical Cancer Treated by a Radical Hysterectomy and Pelvic Lymphadenectomy.
    Cancers (Basel). 2024;17:23.
    PubMed    
    Abstract available

  74. KHOJA L, Zoulfikar M, Hak L, Yousif S, et al
    Overcoming Cultural Barriers and Building Healthcare Trust: A Mixed Methods Study on Cervical Cancer Prevention Among Arab American Women Across Major U.S. Cities.
    Cancers (Basel). 2024;17:5.
    PubMed    
    Abstract available

  75. HOTTON J, Beddok A, Moubtakir A, Papathanassiou D, et al
    [(18)F]FDG PET/CT Radiomics in Cervical Cancer: A Systematic Review.
    Diagnostics (Basel). 2024;15:65.
    PubMed    
    Abstract available

  76. LI T, Zhang H, Lian M, He Q, et al
    Global status and attributable risk factors of breast, cervical, ovarian, and uterine cancers from 1990 to 2021.
    J Hematol Oncol. 2025;18:5.
    PubMed    
    Abstract available

  77. CUBUK F, Yildiz MC, Balci F, Irgin A, et al
    A new approach for detecting HPV DNA in cervical swabs: comparison of nucleic acid extraction with direct PCR.
    Virol J. 2025;22:8.
    PubMed    
    Abstract available

  78. LIAO Z, Hu X, Hu L, Yang J, et al
    High-risk factors and predictive models for hemorrhagic chronic radiation proctitis.
    Eur J Med Res. 2025;30:23.
    PubMed    
    Abstract available

  79. LIU X, Tian W, Dai A, Li H, et al
    A comparative analysis of toxicity and treatment outcomes of adaptive radiotherapy and intensity-modulated radiotherapy in cervical cancer.
    Sci Rep. 2025;15:1609.
    PubMed    
    Abstract available

  80. OMATSU K, Lee CL, Huang KG
    Challenging and continuing laparoscopic radical hysterectomy for more than 30 Years at a single institution. After the LACC trial, should minimally invasive surgery for early-stage cervical cancer really be discarded?
    Taiwan J Obstet Gynecol. 2025;64:82-85.
    PubMed    
    Abstract available

  81. KIM J, Park EB, Lee SW, Park JY, et al
    The real-world efficacy and toxicity of first-line paclitaxel and cisplatin with bevacizumab in platinum-naive primary stage IVB cervical cancer.
    Taiwan J Obstet Gynecol. 2025;64:61-67.
    PubMed    
    Abstract available

  82. GULLI C, Russo L, Gavrila D, Mangialardi M, et al
    Pelvic insufficiency fractures in locally advanced cervical cancer: the diagnostic yield of post-treatment MRI in a tertiary centre.
    Eur J Radiol. 2025;183:111918.
    PubMed    
    Abstract available

  83. LI YT, Yang ST, Wang PH
    Expression of female hormone receptor and prognosis of cervical cancer: Does any relationship exist?
    Taiwan J Obstet Gynecol. 2025;64:6-7.
    PubMed    


  84. LI W, Shi R, Gao Y, Wang X, et al
    CBX2 promotes cervical cancer cell proliferation and resistance to DNA-damaging treatment via maintaining cancer stemness.
    J Biol Chem. 2025 Jan 8:108170. doi: 10.1016/j.jbc.2025.108170.
    PubMed    
    Abstract available

  85. THAPA S, Timilsina A, Bucha B, Shrestha S, et al
    Are we ready for self-sampling for cervical cancer screening? Insights from service providers and policy makers in Nepal.
    PLOS Glob Public Health. 2025;5:e0004114.
    PubMed    
    Abstract available

  86. KONTONIKOU S, Kyrkou G, Bothou A, Nanou C, et al
    Investigation of Women's Knowledge and Beliefs About Cervical Cancer and Cervical Smear Examination: A Survey Study in Greece.
    Cureus. 2024;16:e75486.
    PubMed    
    Abstract available

  87. CHEN L, Li X, Cheng M, Wang S, et al
    Retraction: Iso-pencillixanthone A from a marine-derived fungus reverses multidrug resistance in cervical cancer cells through down-regulating P-gp and re-activating apoptosis.
    RSC Adv. 2025;15:712.
    PubMed    
    Abstract available

  88. ZHAO Y, Chen H, Zhang W, Shang W, et al
    Mir-615-5p inhibits cervical cancer progression by targeting TMIGD2.
    Hereditas. 2025;162:4.
    PubMed    
    Abstract available

  89. AASA M, Lindquist D, Ottander U, Strandberg SN, et al
    Primary staging with 2[18F]-FDG-PET/CT and -PET/MRI and radiotherapy response evaluation with MRI in uterine cervical cancer: an interim analysis of a prospective clinical trial.
    EJNMMI Rep. 2025;9:3.
    PubMed    
    Abstract available

  90. MAYADEV J, Zamarin D, Deng W, Lankes HA, et al
    Neoadjuvant or concurrent atezolizumab with chemoradiation for locally advanced cervical cancer: a randomized phase I trial.
    Nat Commun. 2025;16:553.
    PubMed    
    Abstract available

  91. LIU Z, Luo L, Wu X, Wang B, et al
    Identification of apoptosis-related long non-coding RNAs expression profiles in patient with cervical intraepithelial neoplasia 3.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024;49:1095-1108.
    PubMed    
    Abstract available

  92. YBASETA-MEDINA J, Ybaseta-Soto L, Ossco-Torres O, Aquije-Paredes C, et al
    Sociodemographic, behavioral, and clinical risk factors associated with cervical dysplasia: A case-control study.
    Medwave. 2025;25:e3015.
    PubMed    
    Abstract available

  93. BROTHERTON JM, Vajdic CM, Nightingale C
    The socioeconomic burden of cervical cancer and its implications for strategies required to achieve the WHO elimination targets.
    Expert Rev Pharmacoecon Outcomes Res. 2025.
    PubMed    
    Abstract available

  94. KUTLE I, Polten R, Stalp JL, Hachenberg J, et al
    Anti-Mesothelin CAR-NK cells as a novel targeted therapy against cervical cancer.
    Front Immunol. 2024;15:1485461.
    PubMed    
    Abstract available

  95. TANGKA FKL, Kenney K, Miller J, Howard DH, et al
    Eligibility for and reach of the National Breast and Cervical Cancer Early Detection Program, 2018-2021.
    Cancer Causes Control. 2025 Jan 8. doi: 10.1007/s10552-024-01947.
    PubMed    
    Abstract available

  96. CHEN S, Zhang C, Huang H, Wang Y, et al
    Activation of the WNT4/ beta-catenin/FOXO1 pathway by PDK1 promotes cervical cancer metastasis and EMT process.
    J Mol Histol. 2025;56:68.
    PubMed    
    Abstract available

  97. CAGETTI LV, Gonzague-Casabianca L, Ferre M, Gilhodes J, et al
    The influence of time and implants in high-dose rate image-guided adaptive brachytherapy for locally advanced cervical cancer.
    Brachytherapy. 2025 Jan 7:S1538-4721(24)00463.
    PubMed    
    Abstract available

  98. KAILEMIA PN, Mukami V
    Exploring intersectional determinants of, and interventions for, low uptake of human papillomavirus vaccine in sub-Saharan Africa: a scoping review protocol.
    BMJ Open. 2025;15:e083848.
    PubMed    
    Abstract available

  99. HSIEH CC, Chen SY, Lin CH, Chen SC, et al
    Disability-Adjusted Life Years (DALYs) due to Breast, Cervical, Colorectal and Oral Cancers in Taiwan Regions.
    Cancer Med. 2025;14:e70592.
    PubMed    
    Abstract available

  100. DONATH S, Schirmer MA, Bremmer F, Seif A, et al
    Neoadjuvant radiochemotherapy in patients with high-risk locally advanced cervical cancer-results of a clinical series.
    Strahlenther Onkol. 2025 Jan 8. doi: 10.1007/s00066-024-02340.
    PubMed    
    Abstract available

  101. CASTRO-URIOL D, Vera J, Valcarcel B, Lopez-Ilasaca M, et al
    Exploring the role of Epstein-Barr virus infection on the clinical features and survival in locally advanced cervical cancer: a retrospective cohort study.
    Front Oncol. 2024;14:1522244.
    PubMed    
    Abstract available

  102. MI X, Tuo F, Lin T
    Efficacy and safety of camrelizumab for the treatment of cervical cancer: a systematic review and meta-analysis.
    Front Oncol. 2024;14:1526103.
    PubMed    
    Abstract available


  103. Corrigendum to "It was not normal, and I had to find a doctor and tell him." Kenyan Women's Response to Cervical Cancer Symptoms".
    J Patient Exp. 2025;11:23743735241310655.
    PubMed    
    Abstract available

  104. MINAMITANI M, Katano A, Ohira S, Nakagawa K, et al
    Reply to Iris Batista's Letter to the Editor about "Exploring the Correlation between Health Literacy and Knowledge of Cervical Cancer and Radiotherapy among Japanese Women: A Web-based Survey".
    J Cancer Educ. 2025 Jan 8. doi: 10.1007/s13187-024-02565.
    PubMed    


  105. PATEL D, Thankachan S, Sreeram S, Kavitha KP, et al
    LncRNA-miRNA-mRNA regulatory axes as potential biomarkers in cervical cancer: a comprehensive overview.
    Mol Biol Rep. 2025;52:110.
    PubMed    
    Abstract available

  106. FASHEDEMI O, Ozoemena OC, Peteni S, Haruna AB, et al
    Advances in human papillomavirus detection for cervical cancer screening and diagnosis: challenges of conventional methods and opportunities for emergent tools.
    Anal Methods. 2025 Jan 7. doi: 10.1039/d4ay01921.
    PubMed    
    Abstract available

  107. ZHANG X, Ji J, Zhang Q, Zheng X, et al
    A large annotated cervical cytology images dataset for AI models to aid cervical cancer screening.
    Sci Data. 2025;12:23.
    PubMed    
    Abstract available

  108. DESTAW A, Getachew S, Getachew E, Shita A, et al
    Study protocol for key interventions to improve the follow-up adherence postcervical precancerous lesion treatment in Ethiopia: a pragmatic randomised controlled trial.
    BMJ Open. 2025;15:e091693.
    PubMed    
    Abstract available

  109. HILLEMANNS P, Zikan M, Forget F, Denys HG, et al
    Safety and efficacy of the therapeutic DNA-based vaccine VB10.16 in combination with atezolizumab in persistent, recurrent or metastatic HPV16-positive cervical cancer: a multicenter, single-arm phase 2a study.
    J Immunother Cancer. 2025;13:e010827.
    PubMed    
    Abstract available

  110. FRENEL JS, Mathiot L, Cropet C, Borcoman E, et al
    Durvalumab and tremelimumab in combination with metronomic oral vinorelbine for recurrent advanced cervical cancer: an open-label phase I/II study.
    J Immunother Cancer. 2025;13:e010708.
    PubMed    
    Abstract available

  111. LUVISARO BMO, da Silva TPR, Gusmao JD, Ferraz ML, et al
    Association between contextual factors and vaccine coverage against human papilomavirus in adolescents in the state of Minas Gerais, Brazil: global spatial regressions.
    BMC Infect Dis. 2025;25:34.
    PubMed    
    Abstract available

  112. MASWANGANYE CK, Mkhize PP, Matume ND
    Mapping the HPV Landscape in South African Women: A Systematic Review and Meta-Analysis of Viral Genotypes, Microbiota, and Immune Signals.
    Viruses. 2024;16:1893.
    PubMed    
    Abstract available

  113. LAMSISI M, Benlghazi A, Kouach J, Laraqui A, et al
    Isothermal Nucleic Acid Amplification for Point-of-Care Primary Cervical Cancer Screening.
    Viruses. 2024;16:1852.
    PubMed    
    Abstract available

  114. KEPSHA MA, Timofeeva AV, Chernyshev VS, Silachev DN, et al
    MicroRNA-Based Liquid Biopsy for Cervical Cancer Diagnostics and Treatment Monitoring.
    Int J Mol Sci. 2024;25:13271.
    PubMed    
    Abstract available

  115. VUKOVIC V, Strbac M, Ristic M, Skocibusic S, et al
    Relationship Between Population Density, Availability of Gynecological Services, and Cervical Cancer Incidence and Mortality Across Administrative Units in Serbia and Bosnia and Herzegovina During 2016-2020.
    Medicina (Kaunas). 2024;60:1987.
    PubMed    
    Abstract available

  116. JIANG P, Wu S, Qin W, Xie Y, et al
    Complex Large-Deformation Multimodality Image Registration Network for Image-Guided Radiotherapy of Cervical Cancer.
    Bioengineering (Basel). 2024;11:1304.
    PubMed    
    Abstract available

  117. BOVELL AAN, Ngcamphalala C, Abbott D, Ncayiyana J, et al
    Cost Analysis Related to Diagnosis, Treatment and Management of Cervical Cancer in Antigua and Barbuda: A Prevalence-Based Cost-of-Illness Study.
    Int J Environ Res Public Health. 2024;21:1685.
    PubMed    
    Abstract available

  118. JARA-ROSALES S, Rotarou ES
    Cervical Cancer Screening Uptake Among Women with Disabilities: Findings from a Cross-Sectional Study in Chile.
    Int J Environ Res Public Health. 2024;21:1578.
    PubMed    
    Abstract available

  119. GUTIERREZ-HOYA A, Ortiz-Garrido I, Salazar-Valencia I, Romero-Hernandez C, et al
    Cervical Cancer Cells Use the CD95 and IL-2 Pathways to Promote Their Proliferation and Survival.
    Biomolecules. 2024;14:1543.
    PubMed    
    Abstract available

  120. YU J, Yu T, Yu S, Gao Y, et al
    Short-term efficacy of laparoscopic type C radical hysterectomy by deep uterine vein approach for treatment of cervical cancer.
    Afr J Reprod Health. 2024;28:73-81.
    PubMed    
    Abstract available

  121. FANG H, Tan Y, Sun Y, Wang W, et al
    Effectiveness of nursing care for cervical cancer patients undergoing chemotherapy: Systematic review and meta-analysis.
    Afr J Reprod Health. 2024;28:46-51.
    PubMed    
    Abstract available


  122. RETRACTION: Diagnostic Value for Methylation in Cervical Cancer Based on a Small-Molecule Fluorescent Probe Targeting DNMT1.
    Skin Res Technol. 2024;30:e70155.
    PubMed    


  123. ZHAO R, Kulasingam S
    Cervical Cancer and Cervical Cancer Screening in Women with HIV in Guangxi, China: A Model Simulation Study.
    MDM Policy Pract. 2025;10:23814683241308905.
    PubMed    
    Abstract available

  124. SWANSON M, Ayadi AE, Nakalembe M, Namugga J, et al
    Predictors of delay in the cervical cancer care cascade in Kampala, Uganda.
    Res Sq [Preprint]. 2024 Dec 18:rs.3.rs-5467551. doi: 10.21203/rs.3.rs-5467551.
    PubMed    
    Abstract available

  125. ZHUANG X, Li Y, Zheng H, Fu L, et al
    Evaluating the prognostic relevance of neutrophil-to-lymphocyte ratio in cervical cancer: a systematic review and meta-analysis.
    Front Oncol. 2024;14:1461175.
    PubMed    
    Abstract available

  126. ZOU Z, Fairley CK, Ong JJ, Shen M, et al
    Impact of achieving WHO's 90-70-90 targets on cervical cancer elimination and potential benefits in preventing other HPV-related cancers in China: a modelling study.
    EClinicalMedicine. 2024;77:102878.
    PubMed    
    Abstract available


  127. RETRACTION: Preliminary Evaluation of the Value of a Small-Molecule Probe Targeting DNMT1 in Detecting the Methylation of PAX1 in Cervical Cancer.
    Skin Res Technol. 2024;30:e70157.
    PubMed    


  128. WANG T, Zhang L, Mei S, Wang B, et al
    Single-cell RNA sequencing highlights the unique tumor microenvironment of small cell neuroendocrine cervical carcinoma.
    J Transl Med. 2025;23:19.
    PubMed    
    Abstract available

  129. ISER IC, Bertoni APS, Beckenkamp LR, Consolaro MEL, et al
    Adenosinergic Signalling in Cervical Cancer Microenvironment.
    Expert Rev Mol Med. 2025;27:e5.
    PubMed    
    Abstract available

  130. DI BIAGIO K, Bracci R, Peconi C, Gasperini B, et al
    Differential impact of cervical cancer in immigrant women: a decade-long epidemiological study in the Marche Region, Italy.
    J Epidemiol Community Health. 2025 Jan 6:jech-2024-222564.
    PubMed    
    Abstract available

  131. HUANG H, Ma J, Cui H, Liang T, et al
    Identification of Biomarkers for Cervical Cancer Radiotherapy Sensitivity and Survival Prognosis.
    Oncol Res Treat. 2025 Jan 6:1-20. doi: 10.1159/000543409.
    PubMed    
    Abstract available

  132. SALEH GA, Elged BA, Saleh MM, Hassan A, et al
    The Added Value of Apparent Diffusion Coefficient and Histogram Analysis in Assessing Treatment Response of Locally Advanced Cervical Cancer.
    J Comput Assist Tomogr. 2024 Nov 13. doi: 10.1097/RCT.0000000000001642.
    PubMed    
    Abstract available

  133. LIU Y, Cao L
    Intratumoral Lactobacillus iners as a poor prognostic biomarker and potential therapeutic target for cervical cancer.
    Front Cell Infect Microbiol. 2024;14:1469924.
    PubMed    


  134. WANG M, Wang Z, Zou X, Yang D, et al
    The regulatory role of KIAA1429 in epithelial-mesenchymal transition in cervical cancer via mediating m6A modification of BTG2.
    Cytotechnology. 2025;77:34.
    PubMed    
    Abstract available

  135. FALCARO M, Castanon A, Ndlela B, Sasieni P, et al
    Association between HPV vaccination and cervical screening policy changes and cervical cancer incidence and grade-3 cervical intraepithelial neoplasia incidence in England, 2006-2020: a population-based trends analysis.
    Lancet Reg Health Eur. 2024;49:101157.
    PubMed    
    Abstract available

  136. ZHU H, Wang Y, Zhang Y, Tian Y, et al
    Overexpression of C1orf74 predicts poor outcome and promote cervical cancer progression.
    Heliyon. 2024;10:e40966.
    PubMed    
    Abstract available

  137. PENG P, Zheng J, He K, Wang K, et al
    CENPE is a diagnostic and prognostic biomarker for cervical cancer.
    Heliyon. 2024;10:e40860.
    PubMed    
    Abstract available

  138. CHENG C, Yang Y, Qu Y
    Exploration of Cervical Cancer Image Processing and Detection Based on URCNNs.
    Curr Med Imaging. 2025 Jan 2. doi: 10.2174/0115734056333197241211162651.
    PubMed    
    Abstract available

  139. GILHAM C, Peto J
    Is elimination of cervical cancer in sight in England?
    Prev Med. 2025 Jan 3:108218. doi: 10.1016/j.ypmed.2025.108218.
    PubMed    
    Abstract available

  140. WANG J, Li Z, He Y, Chu Y, et al
    Targeting Siglec-15 mediates mitochondrial retrograde regulation of cervical cancer development.
    Tissue Cell. 2024;93:102713.
    PubMed    
    Abstract available

  141. SHEN S, Zhao S, Shan J, Ren Q, et al
    Metabolomic and microbiota profiles in cervicovaginal lavage fluid of women with high-risk human papillomavirus infection.
    Sci Rep. 2025;15:796.
    PubMed    
    Abstract available

  142. VEGA C, Medina N, Quintana-Quintana L, Leon R, et al
    Feasibility study of hyperspectral colposcopy as a novel tool for detecting precancerous cervical lesions.
    Sci Rep. 2025;15:820.
    PubMed    
    Abstract available

  143. YOKOE T, Oku K, Noda Y, Kita M, et al
    Treatment for SMARCA4-deficient carcinoma of uterine cervix.
    BMJ Case Rep. 2025;18:e258711.
    PubMed    
    Abstract available

  144. STURT A, Omar T, Hansingo I, Kamfwa P, et al
    Association of female genital schistosomiasis and human papillomavirus and cervical pre-cancer: a systematic review.
    BMC Womens Health. 2025;25:2.
    PubMed    
    Abstract available

  145. LYONS MS, Baker C, Chaput G, Finelli A, et al
    Preferred labels and language to improve communication about lesions at low risk of progressing to cancer: qualitative interviews with patients and physicians.
    BMJ Open. 2025;15:e087484.
    PubMed    
    Abstract available

  146. DE MARCO L, Bisanzi S, Ronco G, Mancuso P, et al
    Extended HPV genotyping by the BD Onclarity assay: concordance with screening HPV-DNA assays, triage biomarkers, and histopathology in women from the NTCC2 study.
    Microbiol Spectr. 2025;13:e0089724.
    PubMed    
    Abstract available

  147. YIN L, Zhao Z, Wang C, Zhou C, et al
    Development and evaluation of a CRISPR/Cas12a-based diagnostic test for rapid detection and genotyping of HR-HPV in clinical specimens.
    Microbiol Spectr. 2025;13:e0225324.
    PubMed    
    Abstract available

  148. STOLNICU S, Allison D, Tessier-Cloutier B, Momeni-Boroujeni A, et al
    Presence and extent of lymphovascular invasion in surgical stage I squamous cell carcinoma of the cervix: a comprehensive, international, multicentre, retrospective clinicopathological study.
    Pathology. 2025;57:17-26.
    PubMed    
    Abstract available

  149. IKEDA S, Ueda Y, Yagi A, Mizushima T, et al
    Human papillomavirus vaccine to prevent CIN3 or worse (CIN3+): A nationwide case-control study in Japan.
    Cancer Sci. 2025;116:226-232.
    PubMed    
    Abstract available

  150. RIGORI C, Benelmir S, Porte C, Malincenco M, et al
    [High-grade lesions probability in ASCUS HPV positive patient according to HPV type].
    Gynecol Obstet Fertil Senol. 2025;53:16-19.
    PubMed    
    Abstract available

  151. MEZGER NCS, Seraphin TP, Balle R, Griesel M, et al
    NCCN guideline-concordant cancer care in sub-Saharan Africa: a population-based multicountry study of 5 cancers.
    J Natl Cancer Inst. 2025;117:120-133.
    PubMed    
    Abstract available

  152. KLUITENBERG HARRIS C, Wu HS, Lehto R, Wyatt G, et al
    Relationships Among Determinants of Health, Cancer Screening Participation, and Sexual Minority Identity: A Systematic Review.
    LGBT Health. 2025;12:3-19.
    PubMed    
    Abstract available

  153. ALTAS ZM, Sezerol MA
    Migrant women's perception toward cervical and breast cancer screening in Turkiye: a qualitative analysis.
    BMC Public Health. 2025;25:190.
    PubMed    
    Abstract available

  154. ANJUM S, Akhtar A, Aldaqal SM, Abduh MS, et al
    Enhanced targeted treatment of cervical cancer using nanoparticle-based doxycycline delivery system.
    Sci Rep. 2025;15:2318.
    PubMed    
    Abstract available

  155. WANG T, Jiang R, Tang X, Yao Y, et al
    SOX2 promotes the glycolysis process to accelerate cervical cancer progression by regulating the expression of HK2.
    Acta Histochem. 2025;127:152230.
    PubMed    
    Abstract available

  156. RAO X, Wang YH, Chen RZ, Wu QQ, et al
    Risk-based triage strategy by extended HPV genotyping for women with ASC-US cytology.
    Ann Med. 2025;57:2451183.
    PubMed    
    Abstract available

  157. ONO T, Koto M
    Potential of non-Western medicines in chemoradiotherapy for cervical cancer.
    World J Clin Cases. 2025;13:100198.
    PubMed    
    Abstract available

  158. LIM MC, Choi YJ, Hur SY, Kim YM, et al
    GX-188E DNA vaccine plus pembrolizumab in HPV 16- and/or 18-positive recurrent or advance cervical cancer: a phase 2 trial.
    EClinicalMedicine. 2024;74:102716.
    PubMed    
    Abstract available

  159. TIRO JA, Lykken JM, Chen PM, Clark CR, et al
    Delivering Guideline-Concordant Care for Patients With High-Risk HPV and Normal Cytologic Findings.
    JAMA Netw Open. 2025;8:e2454969.
    PubMed    
    Abstract available

  160. DEREJE N, Addissie A, Worku A, Assefa M, et al
    Barriers to early diagnosis and treatment of cervical cancer in Addis Ababa, Ethiopia: qualitative study.
    BMJ Open. 2025;15:e087792.
    PubMed    
    Abstract available

  161. FARIDZI AS, Ariani Sugianto G, Gumilar KE, Tjokroprawiro BA, et al
    Cervical Neuroendocrine Carcinoma Presenting as Isolated Large Ovarian Metastasis: A Case Report.
    Am J Case Rep. 2025;26:e945078.
    PubMed    
    Abstract available

  162. TELLO-SALGADO I, Torres-Obando A, Mir-Garcia M, Guzman-Razon V, et al
    Cytotoxicity and Cell Death Induction on a Cervical Cancer Cell Line by Crude Extracellular Product of Omphalotus nidiformis (Agaricomycetes) Mycelium.
    Int J Med Mushrooms. 2025;27:35-44.
    PubMed    
    Abstract available

  163. ROY S, Debasmita D, Dey U, Ghosh SS, et al
    Unveiling the Cytotoxic Potential of Quercetin-Loaded Magnetic Bacterial Bots against Cervical Cancer.
    ACS Appl Mater Interfaces. 2025 Jan 16. doi: 10.1021/acsami.4c17079.
    PubMed    
    Abstract available

  164. TONUI P, Itsura P, Omenge O, Faiza N, et al
    Digital cervicography using mobile phones with real-time consultation (DCRC) to improve performance of Visual Inspection with Acetic Acid (VIA) in cervical cancer screening of HIV-infected women. A cross-sectional study.
    Gynecol Oncol Rep. 2024;57:101661.
    PubMed    
    Abstract available

  165. ANNAB A, Lataifeh L, Lataifeh I, Al-Rabadi D, et al
    Factors associated with awareness of and undergoing Pap smear tests among Jordanian women.
    Narra J. 2024;4:e1018.
    PubMed    
    Abstract available

  166. PRATIWI N, Ulfah AJ, Rachmadina R, Irham LM, et al
    Promising candidate drug target genes for repurposing in cervical cancer: A bioinformatics-based approach.
    Narra J. 2024;4:e938.
    PubMed    
    Abstract available

  167. ANAWATE I, Lumley C, Silverwood S, Anchondo M, et al
    Global Review of Tools Evaluating Quality of Life in Cervical Cancer Survivors Treated With Chemoradiation Therapy.
    Adv Radiat Oncol. 2024;10:101700.
    PubMed    
    Abstract available

  168. LOVANE L, Larsson GL, Tulsidas S, Carrilho C, et al
    Endocervical adenocarcinomas and HPV genotyping in an HIV endemic milieu - a retrospective study.
    BMC Womens Health. 2025;25:20.
    PubMed    
    Abstract available

  169. HAMADA K, Yamanoi K, Hayashi N, Kotani Y, et al
    Re-evaluating prognostic factors for cervical cancer with lymph node metastasis: a Japanese multicenter cohort study based on FIGO 2018.
    Int J Clin Oncol. 2025 Jan 16. doi: 10.1007/s10147-025-02697.
    PubMed    
    Abstract available

  170. HAN X, Xia L, Wu Y, Chen X, et al
    m6A-modified circSTX6 as a key regulator of cervical cancer malignancy via SPI1 and IL6/JAK2/STAT3 pathways.
    Oncogene. 2025 Jan 15. doi: 10.1038/s41388-024-03260.
    PubMed    
    Abstract available

  171. AAGAARD M, A Rogvi J, Modin F, Nicolaisdottir D, et al
    Short term complications of conisation and long term effects on fertility related outcomes in Denmark: register based nationwide cohort study.
    BMJ. 2025;388:e078140.
    PubMed    
    Abstract available

  172. LI J, Ye Z, Gan Y, Li D, et al
    TSPOAP1-AS1: A Novel Biomarker for the Prognosis and Therapeutic Target in Cervical Cancer.
    Comb Chem High Throughput Screen. 2025.
    PubMed    
    Abstract available

  173. GARZA-MONTUFAR ME, Carballo-Rosario GD, Garcia-Perez CM
    Hydronephrosis and survival in cervical cancer patients: The role of urinary diversion.
    Gynecol Oncol Rep. 2024;57:101660.
    PubMed    
    Abstract available

  174. BAI Z, Yang Y, Cui Z, Liang W, et al
    Double-targeted liposomes coated with matrix metallopeptidase-2-responsive polypeptide nanogel for chemotherapy and enhanced immunotherapy against cervical cancer.
    Mater Today Bio. 2024;30:101412.
    PubMed    
    Abstract available

  175. CHEN Q, Deng D, Zhu H, Li S, et al
    Single-cell transcriptomics unveils multifaceted immune heterogeneity in early-onset versus late-onset cervical cancer.
    World J Surg Oncol. 2025;23:12.
    PubMed    
    Abstract available

  176. GILLIBRAND S, Gibson H, Howells K, Urwin S, et al
    Exploring the barriers to cervical screening and perspectives on new self-sampling methods amongst under-served groups.
    BMC Health Serv Res. 2025;25:79.
    PubMed    
    Abstract available

  177. HEMLER JR, Wagner RB, Sullivan B, Macenat M, et al
    A Proposed mHealth Intervention to Address Patient Barriers to Colposcopy Attendance: Qualitative Interview Study of Clinic Staff and Patient Perspectives.
    JMIR Form Res. 2025;9:e55043.
    PubMed    
    Abstract available

  178. EL-DALY MM, Faizo AA, Madkhali SA, Aldardeir NF, et al
    Study of the Prevalence of Human Papillomavirus Genotypes in Jeddah, Saudi Arabia.
    J Epidemiol Glob Health. 2025;15:1.
    PubMed    
    Abstract available

  179. ZHAO H, Feng J, Chen J, Wang H, et al
    A Rare Case of Intraoperative Transfusion-associated Hypotension in a Chinese Pregnant Patient.
    Clin Lab. 2025;71.
    PubMed    
    Abstract available

  180. ALJUAID AA
    Hyperproteinemia, Hematuria, and Squamous Cell Shedding in Elderly Cervical Cancer Patients and the Potential Alternative Screening Tool.
    Clin Lab. 2025;71.
    PubMed    
    Abstract available

  181. RIZESCU RA, Salcianu IA, Ionescu A, Serbanoiu A, et al
    The Added Role of Diffusion-Weighted Magnetic Resonance Imaging in Staging Uterine Cervical Cancer.
    Cureus. 2024;16:e75707.
    PubMed    
    Abstract available

  182. SOLEYMANI MAJD H, Gaitskell K, Johnson C, Hellner K, et al
    Cervicitis decidualis mimicking cervical cancer in pregnancy.
    Gynecol Oncol Rep. 2024;57:101663.
    PubMed    
    Abstract available

  183. YOUSAF S, Shehzadi A, Ahmad M, Asrar A, et al
    Recent advances in HPV biotechnology: understanding host-virus interactions and cancer progression - a review.
    Int J Surg. 2024;110:8025-8036.
    PubMed    
    Abstract available

  184. SILVA J, Gama A, Fronteira I, Marques P, et al
    Knowledge and attitudes towards cervical cancer and screening among migrant women: a qualitative study in Portugal.
    BMJ Open. 2024;14:e082538.
    PubMed    
    Abstract available

  185. AGHANEJAD A, Kheiriabad S, Ghaffari M, Namvar Aghdash S, et al
    Targeted co-delivery nanosystem based on methotrexate, curcumin, and PAMAM dendrimer for improvement of the therapeutic efficacy in cervical cancer.
    Sci Rep. 2025;15:1813.
    PubMed    
    Abstract available

  186. GOULENOK T, Francois C, Ferre VM, Mageau A, et al
    Vaginal self-sampling for human papillomavirus to improve cervical cancer screening in patients with immune-mediated inflammatory diseases.
    Eur J Intern Med. 2025 Jan 12:S0953-6205(25)00002.
    PubMed    


  187. MOSCICKI AB, Flowers L, Huchko MJ, Long ME, et al
    Updated Review for Guidelines for Cervical Cancer Screening in Immunosuppressed Women Without HIV Infection.
    J Low Genit Tract Dis. 2025 Jan 13. doi: 10.1097/LGT.0000000000000866.
    PubMed    
    Abstract available

  188. WANG D, Han X, Liu HL
    The role and research progress of tumor-associated macrophages in cervical cancer.
    Am J Cancer Res. 2024;14:5999-6011.
    PubMed    
    Abstract available

  189. FUKUDA T, Ueda M, Aida R, Ota K, et al
    Educational Interventions to Improve Knowledge and Attitudes Toward Human Papillomavirus (HPV) Vaccination and Cervical Cancer Screening Among Japanese University Students.
    Cureus. 2024;16:e75558.
    PubMed    
    Abstract available

  190. DING J, Zhang X, Guo L, Xiong J, et al
    NIR Triggered Bionic Bilayer Membrane-Encapsulated Nanoparticles for Synergistic Photodynamic, Photothermal and Chemotherapy of Cervical Cancer.
    Int J Nanomedicine. 2025;20:141-159.
    PubMed    
    Abstract available

  191. YU R, Yu Q, Shi J, Meng X, et al
    Whole-Genome Methylation Sequencing Analysis and Functional Verification of LIM-Homeobox Family Genes in Cervical Cancer.
    Int J Gen Med. 2025;18:87-102.
    PubMed    
    Abstract available


  192. RETRACTION: Long Noncoding RNA LINC00958 Regulates Cell Sensitivity to Radiotherapy Through RRM2 by Binding to microRNA-5095 in Cervical Cancer.
    J Cell Physiol. 2025;240:e31525.
    PubMed    
    Abstract available

  193. DE ANDRADE FM, de Amorim Andrade SG, Araujo Junior E, Campaner AB, et al
    Pap smear and colposcopy findings in female inmates of a prison unit in the state of Sao Paulo, Brazil.
    Ceska Gynekol. 2024;89:459-468.
    PubMed    
    Abstract available

  194. WU J, Li J, Huang B, Dong S, et al
    ConvXGB: A novel deep learning model to predict recurrence risk of early-stage cervical cancer following surgery using multiparametric MRI images.
    Transl Oncol. 2025;52:102281.
    PubMed    
    Abstract available

  195. TENG Y, Zhao H, Xue G, Zhang G, et al
    Molecule interacting with CasL-2 enhances tumor progression and alters radiosensitivity in cervical cancer.
    J Transl Med. 2025;23:44.
    PubMed    
    Abstract available

  196. WANG R, Gunesli GN, Skingen VE, Valen KF, et al
    Deep learning for predicting prognostic consensus molecular subtypes in cervical cancer from histology images.
    NPJ Precis Oncol. 2025;9:11.
    PubMed    
    Abstract available

  197. EFFAH K, Allotey J, Tekpor E, Wormenor CM, et al
    Nationwide cervical precancer screening in Ghana: concurrent HPV DNA testing and visual inspection under an expanded hub-and-spoke model.
    Sci Rep. 2025;15:1744.
    PubMed    
    Abstract available

  198. BAUMANN K, Peterson CE, Geller S, Awadalla S, et al
    U.S. national trends in cervical cancer screening by sexual orientation and race/ethnicity in cisgender women.
    Prev Med. 2025;191:108223.
    PubMed    
    Abstract available

  199. FOBIAN SF, Amin M, Sacchetti A, Oei AL, et al
    Investigating the delivery of PD-L1-targeted immunoliposomes in a dynamic cervical cancer-on-a-chip model.
    J Control Release. 2025;379:236-250.
    PubMed    
    Abstract available

  200. HOW JA, Jazaeri AA
    Integrating CTLA-4/PD-1 blockade into cervical cancer management: Results of COMPASSION-16.
    Med. 2025;6:100558.
    PubMed    
    Abstract available

  201. BURGER EA, Jansen EEL, de Bondt D, Killen J, et al
    Disparities in cervical cancer elimination timeframes in the United States: a comparative modeling study.
    J Natl Cancer Inst. 2025 Jan 11:djae319. doi: 10.1093.
    PubMed    
    Abstract available

  202. WU H, Li L, Fu K, Shen Y, et al
    Effects of different-valent vaccines against human papillomavirus (HPV) to prevent persistent HPV16/18 infections and CIN2+ in women: a systematic review and network meta-analysis.
    Int J Infect Dis. 2025;151:107363.
    PubMed    
    Abstract available

  203. LIU L, Dollery SJ, Tobin GJ, Lu G, et al
    Cleavable energy transfer labeled oligonucleotide probe for enhanced isothermal amplification detection and nano digital chip-based readout.
    Nanoscale. 2025;17:1381-1391.
    PubMed    
    Abstract available

  204. KIDD EA, Butler SS, Gardner U Jr, Viswanathan AN, et al
    Image guided cervical brachytherapy practice patterns: 2023/2024 survey of the American brachytherapy society.
    Brachytherapy. 2025;24:18-29.
    PubMed    
    Abstract available

  205. OSMANI V, Horner L, Nkurunziza T, Rank S, et al
    Global prevalence of cervical human papillomavirus in women aged 50 years and older with normal cytology: a systematic review and meta-analysis.
    Lancet Microbe. 2025;6:100955.
    PubMed    
    Abstract available

  206. KARIUS A, Shariff M, Schaller S, Lotter M, et al
    Is model-based dose calculation based on cone-beam computed tomography suitable for adaptive treatment planning in brachytherapy?
    Strahlenther Onkol. 2025;201:57-70.
    PubMed    
    Abstract available

  207. GUEVARA BARRERA D, Rodriguez Villalba S, Suso-Marti L, Sanchis-Sanchez E, et al
    Impact of MRI-based planning in transperineal interstitial brachytherapy for locally advanced cervix tumors: Clinical, dosimetric and toxicity outcomes.
    Brachytherapy. 2025;24:134-143.
    PubMed    
    Abstract available

  208. RUI Y, Zhang H, Yu K, Qiao S, et al
    N(6)-Methyladenosine Regulates Cilia Elongation in Cancer Cells by Modulating HDAC6 Expression.
    Adv Sci (Weinh). 2025;12:e2408488.
    PubMed    
    Abstract available

  209. SHIMBE M, Otsuka Y, Hagiya H, Yamada Y, et al
    Human Papillomavirus vaccination awareness and uptake among healthcare students in Japan.
    J Infect Chemother. 2025;31:102554.
    PubMed    
    Abstract available

  210. QIU S, Jiang H, Wang Q, Feng L, et al
    Development of a nomogram for predicting postoperative recurrence of cervical intraepithelial neoplasia using immunohistochemical and clinical parameters.
    Expert Rev Anticancer Ther. 2024;24:1261-1269.
    PubMed    
    Abstract available

  211. YAMAGISHI Y, Nakamura N, Minami M, Keyama K, et al
    Knowledge and awareness of human papillomavirus (HPV) influence HPV vaccination uptake among the catch-up generation in Japan.
    J Infect Chemother. 2025;31:102527.
    PubMed    
    Abstract available

  212. ELLIS SJ
    Improving cervical screening rates among sexual minorities: Insights from Aotearoa New Zealand.
    Health Promot J Austr. 2025;36:e904.
    PubMed    
    Abstract available

  213. TETTEH DA, Dai Z
    Making Sense of Gynecologic Cancer: A Relational Dialectics Approach.
    Health Commun. 2025;40:90-102.
    PubMed    
    Abstract available

  214. PABON-SALAZAR YK, Vela-Prieto CJ, Mera-Urbano GA, Garcia-Perdomo HA, et al
    Advanced breast, cervical and prostate cancer- Patient needs: systematic review.
    BMJ Support Palliat Care. 2024;14.
    PubMed    
    Abstract available

  215. MOHAMMED MM, Al-Khafaji ZAI, Al-Hilli NM
    An exploration of the natural and acquired immunological mechanisms to high-risk human papillomavirus infection and unmasking immune escape in cervical cancer: A concise synopsis.
    Tzu Chi Med J. 2024;37:28-41.
    PubMed    
    Abstract available

  216. SEHRA D, Kumari S
    Malignant peripheral nerve sheath tumour (MPNST) of the cervix: differential diagnosis and a favourable oncological outcome with multimodality treatment.
    BMJ Case Rep. 2025;18:e260709.
    PubMed    
    Abstract available

  217. FLORES-CISNEROS L, Cetina-Perez L, Luvian-Morales J, Galicia-Carmona T, et al
    Fiber, lactose and fat-modified diet for the prevention of gastrointestinal chemo-radiotherapy-induced toxicity in patients with cervical cancer: Randomized clinical trial.
    Nutrition. 2025;132:112682.
    PubMed    
    Abstract available

  218. HOLT HK, Calip GS, Peterson CE, David SM, et al
    Sociodemographic inequities in overall survival among younger and older women with cervical cancer.
    Cancer Causes Control. 2025 Jan 23. doi: 10.1007/s10552-025-01961.
    PubMed    
    Abstract available

  219. GARCIA K, Alvarez G, Iacob E, Kepka D, et al
    Focus Groups With Guatemalan Community Leaders About Barriers to Cervical Cancer Prevention and Control.
    Health Promot Pract. 2025 Jan 23:15248399241309897.
    PubMed    
    Abstract available

  220. WARGANTIWAR S, Bhattacharya S, Kanugo A
    Surgical Advancements, Immunotherapy, Targeted and Conventional Therapies, Biopsy, Colposcopy, and Pap Smear Integration in the Management of Cervical Cancer.
    Curr Med Chem. 2025 Jan 22. doi: 10.2174/0109298673337745241123054840.
    PubMed    
    Abstract available

  221. HARSONO AB, Susiarno H, Suardi D, Mantilidewi KI, et al
    Results comparison of cervical cancer early detection using cerviray (R) with VIA test.
    BMC Res Notes. 2025;18:30.
    PubMed    
    Abstract available

  222. DEVOTTA K, Lofters A, Bender J, O'Campo P, et al
    Perceptions of cervical screening uptake amongst South Asian women in Ontario, Canada: a concept mapping study.
    BMC Public Health. 2025;25:265.
    PubMed    
    Abstract available

  223. ZHANG Z, Chen F, Deng X
    Retraction Note: Screening and identification of susceptibility genes for cervical cancer via bioinformatics analysis and the construction of an mitophagy-related genes diagnostic model.
    J Cancer Res Clin Oncol. 2025;151:42.
    PubMed    


  224. BUI HT, Pham VNH, Vu TH
    Cervical cancer screening by cotesting method for Vietnamese women 25-55 years old: a cost-effectiveness analysis.
    BMJ Open. 2025;15:e082145.
    PubMed    
    Abstract available

  225. BAKER E, MacDonald A, Tennant S
    Approach to cervical polyps in primary care.
    Can Fam Physician. 2025;71:26-30.
    PubMed    
    Abstract available

  226. WU N, Lin F, Ji J, Pan H, et al
    Mitochondrial oxidative stress related LncRNA predict cervical cancer prognosis and immunotherapy response: Molecular structure and protein interaction of ribosomal protein L34.
    Int J Biol Macromol. 2025;299:140145.
    PubMed    
    Abstract available

  227. LI S, Liu C, Weng L
    Exploring Cervical Adenocarcinoma: Epidemiological Insights, Diagnostic and Therapeutic Challenges, and Pathogenetic Mechanisms.
    Cancer Med. 2025;14:e70620.
    PubMed    
    Abstract available

  228. LAPADULA MC, Mohammadrezaei D, Ortigoza A, Freitas A, et al
    Impact of the COVID-19 Pandemic on Cervical Cancer Screening: An International Comparative Study by INTRePID.
    BJOG. 2025 Jan 22. doi: 10.1111/1471-0528.18077.
    PubMed    


  229. LIN Z, Wang F, Yin R, Li S, et al
    Single-cell RNA sequencing and immune microenvironment analysis reveal PLOD2-driven malignant transformation in cervical cancer.
    Front Immunol. 2025;15:1522655.
    PubMed    
    Abstract available

  230. EMAGNENEH T, Mulugeta C, Ejigu B, Alamrew A, et al
    Survival status of women with cervical cancer in Sub-Saharan Africa: a systematic review and meta-analysis, 2024.
    Front Oncol. 2025;14:1491840.
    PubMed    
    Abstract available

  231. SAMUELS A, Badeghiesh A, Baghlaf H, Dahan MH, et al
    Maternal, delivery and neonatal outcomes in women with cervical cancer. A study of a population database.
    Oncoscience. 2025;12:3-12.
    PubMed    
    Abstract available

  232. AN Y, Lei Y, Huang Z, Liu Y, et al
    MacNet: a mobile attention classification network combining convolutional neural network and transformer for the differentiation of cervical cancer.
    Quant Imaging Med Surg. 2025;15:55-73.
    PubMed    
    Abstract available

  233. WENG CS, Chen LL, Cheng SF, Chen TL, et al
    [The Effectiveness of a Pap Smear Screening Practical Skills Training Program for Nurse-Midwifery Students].
    Hu Li Za Zhi. 2025;72:41-50.
    PubMed    
    Abstract available

  234. CHAUHAN S, Tiwari SK, Dubey V, Tripathi P, et al
    Knowledge, attitude, and reasons for non-uptake of human papilloma virus vaccination among nursing students.
    BMC Med. 2025;23:35.
    PubMed    
    Abstract available

  235. IJFF M, Mei X, Scutigliani EM, Rodermond HM, et al
    Addition of PARP1-inhibition enhances chemoradiotherapy and thermoradiotherapy when treating cervical cancer in an in vivo mouse model.
    Int J Hyperthermia. 2025;42:2450514.
    PubMed    
    Abstract available

  236. QI X, Zhou J, Wang X, Shen Y, et al
    HPV E6/E7-Induced Acetylation of a Peptide Encoded by a Long Non-Coding RNA Inhibits Ferroptosis to Promote the Malignancy of Cervical Cancer.
    Adv Sci (Weinh). 2025 Jan 21:e2414018. doi: 10.1002/advs.202414018.
    PubMed    
    Abstract available

  237. ALPAR AD, Ndiaye C, Guillaume D, Limaye RJ, et al
    High unmet needs for cervical cancer screening among women living with HIV in six African countries: A population-based study.
    Int J STD AIDS. 2025 Jan 21:9564624251315787. doi: 10.1177/09564624251315787.
    PubMed    
    Abstract available

  238. LIU L, Liu J, Su Q, Chu Y, et al
    Performance of artificial intelligence for diagnosing cervical intraepithelial neoplasia and cervical cancer: a systematic review and meta-analysis.
    EClinicalMedicine. 2024;80:102992.
    PubMed    
    Abstract available

  239. TANG M
    Research Status of Clustered Regulary Interspaced Short Palindromic Repeats Technology in the Treatment of Human Papillomavirus (HPV) Infection Related Diseases.
    Cancer Control. 2025;32:10732748241300654.
    PubMed    
    Abstract available

  240. XIAO Y, Liu R, Wang S, Wang Y, et al
    Predicting the risk of high-grade precancerous cervical lesions based on high-risk HPV typing in Changsha China.
    BMC Womens Health. 2025;25:28.
    PubMed    
    Abstract available

  241. MANTULA F, Toefy Y, Sewram V
    Strategies for strengthening cervical cancer screening programmes in Gwanda district, Zimbabwe: a qualitative study.
    BMC Public Health. 2025;25:235.
    PubMed    
    Abstract available

  242. SANTOS ACDS, Silva NNT, da Silva IDCG, Carneiro M, et al
    Effectiveness of HPV vaccination in reducing infection among young Brazilian women.
    BMC Infect Dis. 2025;25:88.
    PubMed    
    Abstract available

  243. YAN C, Ma J, Zheng X, Shu J, et al
    Diagnostic accuracy of human papillomavirus testing on self-collected samples among women referred for colposcopy.
    Sci Rep. 2025;15:2513.
    PubMed    
    Abstract available

  244. SHIMELS T, Kantelhardt EJ, Assefa M, Fenta TG, et al
    Spatiotemporal dynamics and prevention strategies of cervical cancer incidence in Addis Ababa, Ethiopia: an ecological study.
    BMJ Open. 2025;15:e089521.
    PubMed    
    Abstract available

  245. JUNG JI, Cho HK
    Unilateral lower extremity lymphedema followed by COVID-19 vaccination in patients with cervical cancer history: two case reports.
    J Yeungnam Med Sci. 2025;42:23.
    PubMed    
    Abstract available

  246. CHEN X, Wang K, Liao X, Zheng X, et al
    Single-Cell RNA Sequencing Reveals the Cellular Origin and Evolution of Small-Cell Neuroendocrine Carcinoma of the Cervix.
    J Med Virol. 2025;97:e70183.
    PubMed    
    Abstract available

  247. NOVAIS IR, Coelho CO, Carvalho CF, Surita F, et al
    The epidemiology of cervical cancer among indigenous women living in Latin America: A systematic review.
    Prev Med Rep. 2024;49:102955.
    PubMed    
    Abstract available

  248. VAN ARSDALE A, Mescheryakova O, Gallego S, Maggi EC, et al
    Serum, Cell-Free, HPV-Human DNA Junction Detection and HPV Typing for Predicting and Monitoring Cervical Cancer Recurrence.
    medRxiv [Preprint]. 2025 Jan 6:2024.09.16.24313343.
    PubMed    
    Abstract available

  249. TEODORO NS, Ngcobo N, Jean-Baptiste M, Mulongo M, et al
    Perspectives on Cervical Cancer Prevention Strategies and a Combination Treatment for Cervical Precancer in South African Women Living with HIV and Male Partners.
    medRxiv [Preprint]. 2025 Jan 7:2025.01.07.25320108.
    PubMed    
    Abstract available

  250. ABRAR SS, Hairon SM, Yaacob NM, Ismail MP, et al
    Global Research Trends in Cervical Cancer Survival in the Last Two Decades: A Bibliometric Analysis.
    Malays J Med Sci. 2024;31:103-111.
    PubMed    
    Abstract available

  251. CHEN Y, Su C, Cai Y, Ke L, et al
    miR-21 promotes cervical cancer by regulating NTF3.
    Sci Rep. 2025;15:2442.
    PubMed    
    Abstract available

  252. GUO W, Ren R, Li N, Hu Y, et al
    Corrigendum to "Prognosis and treatment regimens for patients with different lymph node statuses in locally advanced cervical cancer" [Eur J Surg Oncol. 50 (2024) (11) 108522].
    Eur J Surg Oncol. 2025 Jan 18:109558. doi: 10.1016/j.ejso.2024.109558.
    PubMed    


  253. SUN C, Mustafe AA, Liu B, Ma Y, et al
    Global disease burden of cervical cancer and the association of screening coverage with quality of disease management.
    Zhejiang Da Xue Xue Bao Yi Xue Ban. 2025.
    PubMed    
    Abstract available

  254. LI H, Xu Y, Jiao X, Xu Q, et al
    IBI310 plus sintilimab vs. placebo plus sintilimab in recurrent/metastatic cervical cancer: A double-blind, randomized controlled trial.
    Med. 2025 Jan 15:100573. doi: 10.1016/j.medj.2024.100573.
    PubMed    
    Abstract available

  255. YUE Y, Liu M, Ma M, Xu Z, et al
    CRISPR/Cas14a integrated with DNA walker based on magnetic self-assembly for human papillomavirus type 16 oncoprotein E7 ultrasensitive detection.
    Biosens Bioelectron. 2025;272:117135.
    PubMed    
    Abstract available

  256. BURATO S, D'Aietti A, Paci A, Pellegrini L, et al
    Elevated mortality risks associated with late diagnosis of cancer in individuals with psychiatric disorders?
    J Psychiatr Res. 2025;181:547-552.
    PubMed    
    Abstract available

  257. BEATRICI E, Qian Z, Filipas DK, Stone BV, et al
    Socioeconomic determinants of cancer screening adherence among cancer survivors: analysis from the 2020 Behavioral Risk Factor Surveillance System.
    JNCI Cancer Spectr. 2025;9:pkae127.
    PubMed    
    Abstract available

  258. MAO M, You T, Xu K, Ding H, et al
    TRIM3 modulates cisplmatin-resistant of cervical squamous cell carcinoma via endoplasmic reticulum stress signaling in vitro.
    Biochem Cell Biol. 2025;103:1-12.
    PubMed    
    Abstract available

  259. LAPRISE JF, Chesson HW, Markowitz LE, Drolet M, et al
    Cost-Effectiveness of Extending Human Papillomavirus Vaccination to Population Subgroups Older Than 26 Years Who Are at Higher Risk for Human Papillomavirus Infection in the United States.
    Ann Intern Med. 2024 Nov 26. doi: 10.7326/M24-0421.
    PubMed    
    Abstract available

  260. YAO Y, Wu M, Wang Y, Liao Z, et al
    An Oral PROTAC Targeting HPK1 Degradation Potentiates Anti-Solid Tumor Immunity.
    Adv Mater. 2025;37:e2411454.
    PubMed    
    Abstract available

  261. RAMANADHAN S, Cruz JL, Weese M, Kirk S, et al
    Differing conceptual maps of skills for implementing evidence-based interventions held by community-based organization practitioners and academics: A multidimensional scaling comparison.
    Transl Behav Med. 2025;15:ibae051.
    PubMed    
    Abstract available

  262. KLINE KN, Rangel ML, Bulsara S, Chenier R, et al
    Using Culturally Adapted Theater Outreach to Promote Cancer Screening Among Medically Underserved Minority Communities.
    J Racial Ethn Health Disparities. 2025;12:273-284.
    PubMed    
    Abstract available

  263. CAMPANER AB, Fernandes GL
    Discussion on cervical cytology in postmenopausal women.
    Minerva Obstet Gynecol. 2024;76:532-539.
    PubMed    
    Abstract available

  264. MARKLUND A, Jiang Y, Rojlar H, Sergouniotis F, et al
    The complexity and challenges of fertility preservation in women with cervix cancer-A prospective cohort study reporting on reproductive outcome and overall survival.
    Acta Obstet Gynecol Scand. 2025;104:86-94.
    PubMed    
    Abstract available

  265. REN W, Guo X, Liu Z, Wu Y, et al
    Burden of female-specific cancers in China from 1990 to 2021: A systematic analysis for the Global Burden of Disease Study 2021.
    Cancer. 2025;131:e35712.
    PubMed    
    Abstract available

  266. BAEKER BISPO J, Jemal A, Islami F
    Association of mental health treatment receipt with cancer screening among US adults with a history of anxiety or depression.
    Cancer. 2025;131:e35724.
    PubMed    
    Abstract available

  267. NIERENGARTEN MB
    Overall survival benefit of pembrolizumab plus chemoradiotherapy for patients with high-risk locally advanced cervical cancer.
    Cancer. 2025;131:e35688.
    PubMed    


  268. OAKNIN A, Monk BJ, de Melo AC, Kim HS, et al
    Cemiplimab in recurrent cervical cancer: Final analysis of overall survival in the phase III EMPOWER-Cervical 1/GOG-3016/ENGOT-cx9 trial.
    Eur J Cancer. 2025;216:115146.
    PubMed    
    Abstract available

  269. HELENIUS G, Lillsunde-Larsson G, Karlsson MG, Kaliff M, et al
    Cervical screening with self-sampling for postmenopausal women with molecular triage using extended genotyping and methylation.
    Eur J Obstet Gynecol Reprod Biol. 2025;305:404-409.
    PubMed    
    Abstract available

  270. LEIJTENS L, Piek J, Verrijssen AS, Rijkaart D, et al
    Thromboprophylaxis in patients with locally advanced cervical cancer treated with chemoradiation and brachytherapy.
    Gynecol Oncol. 2025;193:41-48.
    PubMed    
    Abstract available

  271. VERHOEF L, Bleeker MCG, Polman N, Kroon KR, et al
    Colposcopy referrals and CIN3 detection after triage by host cell DNA methylation and/or HPV genotyping in HPV positive women with low-grade cytology from a population-based Dutch primary HPV screening trial.
    Int J Cancer. 2024 Dec 16. doi: 10.1002/ijc.35289.
    PubMed    
    Abstract available

  272. CHEN Q, Yao X, Quan J, Jia X, et al
    The variations in the natural history of high-risk human papillomavirus infections in Chinese healthy women aged 27-45 years compared with 18-26 years: A prospective cohort study.
    Int J Cancer. 2025;156:1043-1054.
    PubMed    
    Abstract available

  273. KEN-AMOAH S, Redl E, Domson BKS, Barrett JE, et al
    Performance of the WID-qEC test to detect uterine cancers in black women with abnormal uterine bleeding: A prospective observational cohort study in Ghana.
    Int J Cancer. 2024 Dec 10. doi: 10.1002/ijc.35260.
    PubMed    
    Abstract available

  274. SCHAAFSMA M, Schuurman TN, Kootstra P, Issa D, et al
    Nationwide cohort study on the risk of high-grade cervical dysplasia and carcinoma after conservative treatment or hysterectomy for adenocarcinoma in situ.
    Int J Cancer. 2024 Nov 4. doi: 10.1002/ijc.35237.
    PubMed    
    Abstract available

  275. TAKAMOTO N, Aso S, Ishida R, Konishi T, et al
    Cost-effectiveness analysis of 9-valent human papillomavirus vaccine combined with screening for cervical cancer in Japan.
    Int J Gynaecol Obstet. 2024 Dec 28. doi: 10.1002/ijgo.16125.
    PubMed    
    Abstract available

  276. CUBAKA NTAMUSHIGO J, Motshedisi Sebitloane H
    Review of triage strategies for atypical squamous cells of undetermined significance among young women.
    Int J Gynaecol Obstet. 2025;168:428-435.
    PubMed    
    Abstract available

  277. CAO Y, Xiao X, Liang D, Lu Y, et al
    HPV 16/18 E7 oncoprotein detection as a promising triage strategy for HPV 16/18-positive patients: A prospective multicenter study with a 2-year follow up.
    Int J Gynaecol Obstet. 2024 Sep 8. doi: 10.1002/ijgo.15897.
    PubMed    
    Abstract available

  278. YIM GW, Lee J, Yang K, Lee CH, et al
    A pilot study of upcycled smartphone-based colposcopy for visual inspection of cervix performed by community healthcare workers in rural Vietnam.
    Int J Gynaecol Obstet. 2025;168:518-524.
    PubMed    
    Abstract available

  279. LI Y, Zhao J, Ding X, Liang C, et al
    Oncologic Outcomes of Laparoscopic Radical Hysterectomy Incorporating Modified Tumor-Free Techniques.
    Obstet Gynecol. 2024 Dec 19. doi: 10.1097/AOG.0000000000005805.
    PubMed    
    Abstract available

  280. WU Z, Lu L, Xu C, Wang D, et al
    Development and external validation of a multi-task feature fusion network for CTV segmentation in cervical cancer radiotherapy.
    Radiother Oncol. 2024;204:110699.
    PubMed    
    Abstract available

  281. ZHANG Z, Xie C, Zhao R, Wang S, et al
    Detecting epithelial-mesenchymal transition signaling molecules in cervical epithelial cells aids in the early diagnosis of cervical lesions.
    BMC Cancer. 2024;24:1582.
    PubMed    
    Abstract available

  282. SHEN T, Dong T, Wang H, Ding Y, et al
    Integrative machine learning frameworks to uncover specific protein signature in neuroendocrine cervical carcinoma.
    BMC Cancer. 2025;25:57.
    PubMed    
    Abstract available

  283. BA-ALAWI E, Azzani M, Alsaidi NA, Atroosh WM, et al
    Barriers to cervical cancer screening among immigrant Yemeni women in Malaysia.
    BMC Cancer. 2025;25:4.
    PubMed    
    Abstract available

  284. BOVELL AAN, Ramaliba T, Goodwin SO, Phillip JC, et al
    Incidence, trends and patterns of female breast, cervical, colorectal and prostate cancers in Antigua and Barbuda, 2017-2021: a retrospective study.
    BMC Cancer. 2025;25:72.
    PubMed    
    Abstract available

  285. GARG P, Krishnamoorthy Y, Halder P, Rajaa S, et al
    Urban-rural disparities in cervical cancer screening among Indian women between 30-49 years: a geospatial and decomposition analysis using a nationally representative survey.
    BMC Cancer. 2025;25:67.
    PubMed    
    Abstract available

  286. WAGNER-LARSEN KS, Lura N, Gulati A, Ryste S, et al
    MRI delta radiomics during chemoradiotherapy for prognostication in locally advanced cervical cancer.
    BMC Cancer. 2025;25:122.
    PubMed    
    Abstract available

  287. KHASAWNEH AI, Al Shboul S, Himsawi N, Al Rousan A, et al
    Resolution of oncogene-induced senescence markers in HPV-infected cervical cancer tissue.
    BMC Cancer. 2025;25:111.
    PubMed    
    Abstract available

  288. YAO Q, Wang J, Elfstrom KM, Strander B, et al
    Evaluation of primary HPV-based cervical screening among older women: Long-term follow-up of a randomized healthcare policy trial in Sweden.
    PLoS Med. 2024;21:e1004505.
    PubMed    
    Abstract available

  289. CAO Q, Hou Y, Wang C, Yin J, et al
    Effect of human papillomavirus (HPV) vaccination on HPV infection and recurrence of HPV related disease after local surgical treatment: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0312128.
    PubMed    
    Abstract available

  290. BHENGU P, Ndwandwe D, Cooper S, Katoto PDMC, et al
    Behavioural and social drivers of human papillomavirus vaccination in eThekwini District of KwaZulu-Natal Province, South Africa.
    PLoS One. 2024;19:e0311509.
    PubMed    
    Abstract available

  291. DE FOUW M, Boere MWM, Nakisige C, Nabwire M, et al
    Cervical cancer care at a tertiary oncology facility in Uganda: Comparing daily practice with national treatment targets on cervical cancer control.
    PLoS One. 2025;20:e0316323.
    PubMed    
    Abstract available

  292. OHYA A, Miyamoto T, Ichinohe F, Kobara H, et al
    Problems of magnetic resonance diagnosis for gastric-type mucin-positive cervical lesions of the uterus and its solutions using artificial intelligence.
    PLoS One. 2024;19:e0315862.
    PubMed    
    Abstract available

  293. TAKAHASHI Y, Sasamori Y, Higuchi R, Kaku A, et al
    Effects of different educational interventions on cervical cancer knowledge and human papillomavirus vaccination uptake among young women in Japan: Preliminary results of a cluster randomized controlled trial.
    PLoS One. 2025;20:e0311588.
    PubMed    
    Abstract available

  294. KHOMPHAIBOONKIJ U, Sreamsukcharoenchai N, Pitakkarnkul S, Rittiluechai K, et al
    Correction: Knowledge of Thai women in cervical cancer etiology and screening.
    PLoS One. 2025;20:e0318184.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.


;